Bohle Coating – Bohle Film Coater BFC
The BFC is the high-end version of the Bohle coater designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available.
Bohle coaters guarantee excellent product processing with exceptionally high profitability. The flat tablet bed in long drum geometry, as well as the continuous adjustment of the inclination angle ensures optimal movement of the cores. The integrated mixing spirals in the drum enable continuous product movement. There is no tablet twinning, therefore minor losses in solids and coatings.
Innovative concepts for processes as well as for cleaning improve the coater functionality and deliver outstanding results.
The type of air system reveals significant process-related advantages. Danger of spray drying of suspension no longer exists. This reduces spray losses and improves the structure of the coating. Tablets are handled more carefully thanks to the pan geometry and the mixing and conveyor elements. Through change of direction of pan rotation, tablets can be discharged completely and without containments.
The Bohle film coater BFC is the high-end version of the Bohle coater series designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available.
Marketing Manager
Tobias Borgers
t.borgers@lbbohle.de
+49 2524 – 9323 0
www.lbbohle.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
